![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 17, 2020 4:25:43 PM
I believe most of the other products under development are largely intended to treat coronavirus once it's been diagnosed, but by the time people have developed pneumonia, they will be of little benefit. Once pneumonia develops, hopefully PLX-PAD can be applied, ideally before a ventilator is needed, but certainly once people are being put on ventilators. I'm of the belief that if it's used prior to requiring a ventilator, far fewer will advance to the point where they need it.
We have roughly a month before the numbers are greatly reduced, not that there still won't be many patients to treat, but it might be a tiny fraction of the number on ventilators today. If we can get this done before most State's return to some degree of normalcy, should it reemerge in the Fall or Winter we'll be approved by then, and the death rate should be greatly diminished. It won't end the threat, but it will be less deadly, and then we should get a vaccine. If we get that approval, we'll be saving a lot of lives in the future as it becomes the SOC for the treatment of pneumonia regardless of the cause.
Gary
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM